Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mark R Hopkins"'
Autor:
Tomoyasu Higashimoto, Christy Haakonsen Smith, Mark R. Hopkins, John Gross, Deyin Xing, Jae W. Lee, Traevia Morris, Joann Bodurtha
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 10, Iss 9, Pp n/a-n/a (2022)
Abstract Background Ovarian sex cord‐stromal tumors (OSCTs) are rare ovarian tumors that can develop from sex cord, stromal cells, or both. OSCTs can be benign or malignant. Bilateral and/or unilateral ovarian fibromas, a type of OSCT of the stroma
Externí odkaz:
https://doaj.org/article/3a148da568804f30999342c133c5df6b
Autor:
Mark R, Hopkins, Doreen N, Palsgrove, Brigitte M, Ronnett, Russell, Vang, Jeffrey, Lin, Tricia A, Murdock
Publikováno v:
American Journal of Surgical Pathology. 46:1611-1622
Human papillomavirus (HPV)-independent primary endometrial squamous cell carcinoma (PESCC) is a rare but aggressive subtype of endometrial carcinoma for which little is known about the genomic characteristics. Traditional criteria have restricted the
Autor:
Tricia Murdock, Wissam Dahoud, Russell Vang, Aaron Varghese, Rebecca N. Baergen, Mark R Hopkins, Caitlin Alexander, Frederic B. Askin, Deyin Xing, J. Kenneth Schoolmeester
Publikováno v:
American Journal of Surgical Pathology. 46:258-267
Bizarre (atypical/symplastic) cells have been described in various gynecologic normal tissues and benign neoplasms. This type of bizarre cytologic change is usually an incidental finding and is regarded as a benign process. We describe 17 cases of bi
Autor:
Henry F. VanBrocklin, Ella F. Jones, Christopher R. Drake, Hendry Cahaya, Sophia K. Beyer, Jonathan J. Geruntho, Shorouk Dannoon, Melanie Regan, Mark R. Hopkins, Lubica Skultetyova, Tanushree Ganguly, Salma Jivan, Cyril Barinka, Clifford E. Berkman, Cindy J. Choy, Matthew S. Galliher, Joseph E. Blecha
Publikováno v:
Journal of medicinal chemistry, vol 59, iss 12
A series of phosphoramidate-based prostate specific membrane antigen (PSMA) inhibitors of increasing lipophilicity were synthesized (4, 5, and 6), and their fluorine-18 analogs were evaluated for use as positron emission tomography (PET) imaging agen
Autor:
Clifford E. Berkman, Hendry Cahaya, Stephanie T. Murphy, Joseph E. Blecha, Shorouk Dannoon, Tanushree Ganguly, Salma Jivan, Ella F. Jones, Cyril Barinka, Christopher R. Drake, Henry F. VanBrocklin, Mark R. Hopkins
Publikováno v:
Nuclear medicine and biology, vol 42, iss 10
Introduction In this study, a structurally modified phosphoramidate scaffold, with improved prostate-specific membrane antigen (PSMA) avidity, stability and in vivo characteristics, as a PET imaging agent for prostate cancer (PCa), was prepared and e
Autor:
Clifford E. Berkman, Marc O. Anderson, Melody D. Fulton, Joseph K. Choi, Cindy J. Choy, Mark R. Hopkins, Austen L. Davis
Publikováno v:
Chemical Biology & Drug Design. 82:612-619
Glutamate carboxypeptidase II (GCPII) is a membrane-bound cell surface peptidase. There is significant interest in the inhibition of GCPII as a means of neuroprotection, while GCPII inhibition as a method to treat prostate cancer remains a topic of f
Autor:
Clifford E. Berkman, Paul D. Benny, Jessie R. Nedrow-Byers, Melody D. Fulton, Adam L Moore, Tanushree Ganguly, Mark R. Hopkins
Publikováno v:
The Prostate. 73:355-362
The enzyme-biomarker prostate-specific membrane antigen (PSMA) is an active target for imaging and therapeutic applications for prostate cancer. The internalization of PSMA has been shown to vary with inhibitors' mode of binding: irreversible, slowly
Autor:
Tanushree Ganguly, Clifford E. Berkman, Gerhard R. Munske, Margaret E. Black, Mark R. Hopkins, Melody D. Fulton, Stacy E. Martin
Publikováno v:
Bioconjugate Chemistry
Prostate cancer (PCa) is the second most common cause of cancer death among American men after lung cancer. Unfortunately, current therapies do not provide effective treatments for patients with advanced, metastatic, or hormone refractory disease. Th
Autor:
Susan A. Davidson, Georgina Cheng, Monique A. Spillman, Saketh R. Guntupalli, Mark R. Hopkins, Abby M. Richmond, Miriam D. Post, Jeanelle Sheeder
Publikováno v:
JSLS : Journal of the Society of Laparoendoscopic Surgeons
Background: Minimally invasive surgery has become a standard treatment for endometrial cancer and offers significant benefits over abdominal approaches. There are discrepant data regarding lymphovascular space invasion (LVSI) and positive peritoneal
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 20:7124-7126
Prostate-specific membrane antigen (PSMA) remains an active target for imaging and therapeutic applications for prostate cancer. Although radionuclide-based imaging is generally more sensitive and also has been deeply explored, near-infrared fluoresc